Table 1.
The demographic characteristics and patient details
| Study | Treatmentregimen | Numberof patients | Year | Female/male (n) | Study type | Age (mean 6SD) (years) | Race | Follow-up(years) |
|---|---|---|---|---|---|---|---|---|
| Tallstedt et al. | Antithyroid drug plus thyroxine65/subtotal thyroidectomy followed by thyroxine 64 | 65/64 | 1992 | 107/22 | RCT | Young adults:28±4 old adults: 45±6 | Sweden | 2 |
| Trgring et al. | Antithyroid drugs plus T4/subtotal thyroidectomy followed by T4 | 71/67 | 1996 | 113/25 | RCT | Young adults:29±4 old adults: 45±6 | Sweden | 2 |
| Ljunggren et al. | Antithyroid drug plus thyroxine/subtotal thyroidetomy followed by thyroxine | 68/76 | 1998 | NR | RCT | NR | Sweden | 2 |
| Abraham Nordlin et al. | Antithyroid drugs plus/subtotal thyroidectomy followed by thyroxine thyroxine | 55/56 | 2005 | NR | RCT | NR | Sweden | 1.5 |
| P Laurberg et al. | Antithyroid drugs plus L-thyroxine/ subtotal thyroidectomy followed byL-T4 | 48/47 | 2008 | NR | RCT | NR | Sweden | 2 |
| Ta et al. | Anti-thyroid drugs/subtotal thyroidectomy | 28/28 | 2010 | 12/72 | RCT | 35.83±12.01 | China | 1 |
| Erdoğan et al. | Antithyroid drug /total thyroidectomy | 18/24 | 2016 | Total thyroidectomy:7/11 antithyroid drug:12/12 | RCT | Total thyroidectomy:44±8.7 antithyroid drug:35±12.9 | Britain | 3 |